Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Formulation and Evaluation of Gastroretentive Floating Dosage Forms of Clarithromycin


Affiliations
1 Maharajah’s College of Pharmacy, Phool Baugh, Vizianagaram – 535002, Andhra Pradesh, India
2 Department of Pharmaceutical Technology, A. U. College of Pharmaceutical Sciences, Andhra University, Visakhapatnam – 530 003, India
     

   Subscribe/Renew Journal


The objective of the present investigation is to formulate gastro retentive floating drug delivery systems (GRFDDS) of clarithromycin for the treatment of Helicobacter pylori, to prolong the gastric residence time after oral administration, at a particular site and controlling the release of drug especially useful for achieving controlled plasma level as well as improving bioavailability and to study the effect of formulation variables on floating lag time, t50 (time required to release 50% of the drug) and t90 (time required to release 90% of the drug). The GRFDDS contains hydroxypropyl methylcellulose (HPMC) and hydroxyl propyl cellulose (HPC) as a release retarding polymer. The concentration of sodium bicarbonate (NaHCo3) was optimized. The tablets were prepared by wet granulation method. The prepared tablets were evaluated for all their physicochemical properties, in vitro buoyancy, drug release and rate order kinetics. From the results, FHM4 was selected as an optimized formulation based on their 12 hrs drug release, minimal floating lag time and maximum total floating time. The optimized formulation followed first order rate kinetics with erosion mechanism. The optimized formulation was characterized with FTIR studies and no interaction between the drug and the polymers were observed.

Keywords

Clarithromycin, Gastro Retentive, Floating, Hydroxypropyl Methylcellulose and Hydroxyl Propyl Cellulose.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Alexander Streubel, Juergen Siepmann, and Roland Bodmeier. “Drug Delivery to the Upper Small Intestine Window Using Gastroretentive Technologies”. Current Opinion in Pharmacology, Science Direct. 2006, 6; 501–508.
  • AV Mayavanshi and SS Gajjar. “Floating Drug Delivery Systems to Increase Gastric Retention of Drugs”. Research J. Pharm. and Tech. 1(4): Oct.-Dec. 2008; 345-348.
  • Irin Dewan, Md. Elias-Al-Mamun and Reza-ul Jalil. “Studies on Swelling Behavior of HPMC Based Matrix Tablets by the Application of Digital Imaging Technique”. Dhaka Univ. J. Pharm. Sci. 7(2), 2008 (December); 169-175.
  • Muralidhar Nama, Chandra Sekhar Rao Gonugunta, and Prabhakar Reddy Veerareddy. “Formulation and Evaluation of Gastroretentive Dosage Forms of Clarithromycin”. AAPS Pharm Sci Tech, 9(1), March 2008, 231-237.
  • Indian Pharmacopoeia, Govt. Of India, Ministry of Health and Family Welfare, the Indian Pharmacopoeia Commision, Ghaziabad, India, Vol. I, 2007, 183.
  • Srikanth MV, Sreenivasa Rao N, Sunil SA, Sharma GS, Uhumwangho MU, Ramana murthy KV. Formulation and evaluation of gastro retentive floating drug delivery system of ofloxacin. Drug Inv Today 2011;3(3):7-9.
  • Wagner JG. Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J Pharm Sci 1969, 58:1253.
  • Higuchi T. Mechanism of sustained action medication: Theoretical analysis of rate release of solid drugs dispersed in solid matrices. J Pharm Sci 1963, 52: 1145-1149.
  • Korsmeyer R, Gurny R, Peppas N. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 1983, 15: 25-35.
  • Hixson AW, Crowell JH. Dependence of reaction velocity upon surface and agitation (I) theoretical consideration. Ind Eng Chem 1931, 23: 923-931.
  • Shashikant D. Barhate, Dr. Madhabhai M. Patel, Amol B. Patil, Sandeep R. Pawar and Sumit R. Rathi. “Formulation and optimization of controlled released floating tablets of Clarithromycin”. Journal of Pharmacy Research. 2(3), March 2009; 445-448.
  • Sanjay S. Patel, S. Ray and R. S. Thakur. “Formualtion and Evaluation OF Floating Drug Delivery System Containing Clarithromycin for Helicobacter pylori”. Acta Poloniae Pharmaceutica Drug Research, 63 (1), 2006: 53-61.
  • US Pharmacopoeia 30-NF25, The official compendia of standards, National Publishing, Philadelphia, PA: 3058.

Abstract Views: 212

PDF Views: 0




  • Formulation and Evaluation of Gastroretentive Floating Dosage Forms of Clarithromycin

Abstract Views: 212  |  PDF Views: 0

Authors

Saripilli Rajeswari
Maharajah’s College of Pharmacy, Phool Baugh, Vizianagaram – 535002, Andhra Pradesh, India
Koralla Hari
Maharajah’s College of Pharmacy, Phool Baugh, Vizianagaram – 535002, Andhra Pradesh, India
K. V. Ramana Murthy
Department of Pharmaceutical Technology, A. U. College of Pharmaceutical Sciences, Andhra University, Visakhapatnam – 530 003, India

Abstract


The objective of the present investigation is to formulate gastro retentive floating drug delivery systems (GRFDDS) of clarithromycin for the treatment of Helicobacter pylori, to prolong the gastric residence time after oral administration, at a particular site and controlling the release of drug especially useful for achieving controlled plasma level as well as improving bioavailability and to study the effect of formulation variables on floating lag time, t50 (time required to release 50% of the drug) and t90 (time required to release 90% of the drug). The GRFDDS contains hydroxypropyl methylcellulose (HPMC) and hydroxyl propyl cellulose (HPC) as a release retarding polymer. The concentration of sodium bicarbonate (NaHCo3) was optimized. The tablets were prepared by wet granulation method. The prepared tablets were evaluated for all their physicochemical properties, in vitro buoyancy, drug release and rate order kinetics. From the results, FHM4 was selected as an optimized formulation based on their 12 hrs drug release, minimal floating lag time and maximum total floating time. The optimized formulation followed first order rate kinetics with erosion mechanism. The optimized formulation was characterized with FTIR studies and no interaction between the drug and the polymers were observed.

Keywords


Clarithromycin, Gastro Retentive, Floating, Hydroxypropyl Methylcellulose and Hydroxyl Propyl Cellulose.

References